Advances in Multiple Myeloma: Insights from Experts at Emory University on Translating Evidence to Clinical Practice - Episode 2

Newly Diagnosed Multiple Myeloma: The MASTER and GMMG-HD7 Trials

, , ,

A review of the study design and results of two clinical trials researching quadruplet therapies for newly diagnosed multiple myeloma presented at ASH 2021.

EP. 1: Emory Experts Discuss Multi-Agent Induction Regimens for Transplant-Eligible Newly Diagnosed Myeloma
Now Viewing
EP. 2: Newly Diagnosed Multiple Myeloma: The MASTER and GMMG-HD7 Trials
EP. 3: Treatment Approaches for Patients with Newly Diagnosed Multiple Myeloma
EP. 4: Maintenance Therapy Strategies for Transplant Eligible Multiple Myeloma
EP. 5: Case Presentation: An 82-Year-Old Woman with Transplant-Ineligible Multiple Myeloma
EP. 6: Transplant-Ineligible Multiple Myeloma: The MAIA Trial
EP. 7: Defining High-Risk Multiple Myeloma
EP. 8: Transplant-Ineligible Multiple Myeloma: The SWOG0777 Study